APROVE : Irbesartan in Hypertension

NCT00283036 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Irbesartan

Sponsor

Sanofi

Collaborators

[object Object]